Clinical and immunological features for early differentiation between primary immune thrombocytopenia and connective tissue disease in children

Fu-Rong KANG, Mei YAN, Ying-Bin YUE, Hailiguli NURIDDIN, Yong-Feng CHENG, Yu LIU

Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (8) : 974-981.

PDF(1097 KB)
PDF(1097 KB)
Chinese Journal of Contemporary Pediatrics ›› 2025, Vol. 27 ›› Issue (8) : 974-981. DOI: 10.7499/j.issn.1008-8830.2411121
CLINICAL RESEARCH

Clinical and immunological features for early differentiation between primary immune thrombocytopenia and connective tissue disease in children

Author information +
History +

Abstract

Objective To investigate the clinical and immunological features of children with primary immune thrombocytopenia (pITP) or connective tissue disease (CTD) with thrombocytopenia as the initial manifestation at initial diagnosis, and to provide a basis for early differentiation. Methods A retrospective study was performed on 236 children with pITP (pITP group) or CTD with thrombocytopenia as the initial manifestation (CTD-TP group) who were admitted from January 2019 to August 2024. Clinical and immunological indicators were compared between the two groups to identify potential influencing factors for early differentiation and their discriminative validity. Results Compared with the pITP group, the CTD-TP group had a significantly older age of onset and significantly lower leukocyte count, eosinophil count, lymphocyte count, and complement C4 level (P<0.05), as well as significantly higher levels of C-reactive protein, IgE, and IgM (P<0.05). The logistic regression analysis showed that age, IgE, IgM, total B cells, and complement C4 were predictive factors for early differentiation between pITP and CTD-TP (P<0.05). The receiver operating characteristic curve analysis showed that a combination of these five factors had a good discriminative validity, with an area under the curve of 0.944. The correlation analysis showed a negative correlation between IgG and platelet count in the pITP group (rs =-0.363, P<0.05) and a positive correlation between NK cells and platelet count in the CTD-TP group (rs =0.713, P<0.05). Conclusions There is heterogeneity in the clinical and immunological indicators between children with pITP and CTD-TP at initial diagnosis, and these research findings can help with the early differentiation between the two diseases.

Key words

Primary immune thrombocytopenia / Thrombocytopenia / Connective tissue disease / Child

Cite this article

Download Citations
Fu-Rong KANG , Mei YAN , Ying-Bin YUE , et al . Clinical and immunological features for early differentiation between primary immune thrombocytopenia and connective tissue disease in children[J]. Chinese Journal of Contemporary Pediatrics. 2025, 27(8): 974-981 https://doi.org/10.7499/j.issn.1008-8830.2411121

References

[1]
Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood Adv, 2019, 3(22): 3780-3817. PMCID: PMC6880896. DOI: 10.1182/bloodadvances.2019000812 .
[2]
LeVine DN, Brooks MB. Immune thrombocytopenia (ITP): pathophysiology update and diagnostic dilemmas[J]. Vet Clin Pathol, 2019, 48(): 17-28. DOI: 10.1111/vcp.12774 .
Suppl 1
[3]
Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia[J]. Blood Adv, 2019, 3(23): 3829-3866. PMCID: PMC6963252. DOI: 10.1182/bloodadvances.2019000966 .
[4]
Quintana-Ortega C, Remesal A, Vigara AP, et al. Severe thrombocytopenia as the main manifestation of childhood-onset systemic lupus erythematosus[J]. Mediterr J Rheumatol, 2022, 33(4): 459-464. PMCID: PMC10075375. DOI: 10.31138/mjr.33.4.459 .
[5]
Tahir S, Ashraf NN, Rizwanullah, et al. Systemic lupus erythematosus presenting as isolated thrombocytopenia: a case report and review of the literature[J]. Cureus, 2024, 16(8): e68354. PMCID: PMC11446585. DOI: 10.7759/cureus.68354 .
[6]
Bashyal KP, Shah S, Ghimire C, et al. Primary immune thrombocytopenic purpura (ITP) and ITP associated with systemic lupus erythematosus: a review of clinical characteristics and treatment modalities[J]. Int J Rheumatol, 2024, 2024: 6650921. PMCID: PMC10923624. DOI: 10.1155/2024/6650921 .
[7]
Wang J, Dai M, Fu Q, et al. Eltrombopag for the treatment of refractory thrombocytopenia associated with connective tissue disease[J]. Sci Rep, 2021, 11(1): 5459. PMCID: PMC7943759. DOI: 10.1038/s41598-021-84493-2 .
[8]
国家卫生健康委. 儿童原发性免疫性血小板减少症诊疗规范(2019年版)[J]. 全科医学临床与教育, 2019, 17(12): 1059-1062. DOI: 10.13558/j.cnki.issn1672-3686.2019.012.002 .
[9]
Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts[J]. Arthritis Rheumatol, 2017, 69(1): 35-45. PMCID: PMC5650478. DOI: 10.1002/art.39859 .
[10]
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185. DOI: 10.3760/cma.j.issn.0578-1426.2020.03.002 .
[11]
莫颖倩, 严青, 叶霜, 等. 未分化结缔组织病和混合性结缔组织病的诊疗规范[J]. 中华内科杂志, 2022, 61(10): 1119-1127. DOI: 10.3760/cma.j.cn112138-20220104-00009 .
[12]
中国儿童原发性免疫性血小板减少症诊断与治疗指南改编工作组, 中华医学会儿科学分会血液学组, 中华儿科杂志编辑委员会. 中国儿童原发性免疫性血小板减少症诊断与治疗改编指南(2021版)[J]. 中华儿科杂志, 2021, 59(10): 810-819. DOI: 10.3760/cma.j.cn112140-20210509-00397 .
[13]
Fu Y, Zhao L, Ye S. Intention to treat: the management of connective tissue disease-related immune thrombocytopenia[J]. Int J Rheum Dis, 2023, 26(10): 1885-1888. DOI: 10.1111/1756-185X.14811 .
[14]
Meena DS, Bohra GK. Primary Sjogren's syndrome presenting as autoimmune cytopenia[J]. Clin Pract, 2019, 9(4): 1190. PMCID: PMC6955628. DOI: 10.4081/cp.2019.1190 .
[15]
Li S, Xue Y, Kuang W, et al. Age-related differences in clinical and laboratory characteristics of childhood-onset systemic lupus erythematosus: pre-puberal-onset SLE is prone to delayed diagnosis[J]. Lupus, 2023, 32(14): 1675-1680. DOI: 10.1177/09612033231212522 .
[16]
Santacruz JC, Mantilla MJ, Rueda I, et al. A practical perspective of the hematologic manifestations of systemic lupus erythematosus[J]. Cureus, 2022, 14(3): e22938. PMCID: PMC8986464. DOI: 10.7759/cureus.22938 .
[17]
Cheloff AZ, Kuter DJ, Al-Samkari H. Serum complement levels in immune thrombocytopenia: characterization and relation to clinical features[J]. Res Pract Thromb Haemost, 2020, 4(5): 807-812. PMCID: PMC7354388. DOI: 10.1002/rth2.12388 .
[18]
Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus?[J]. Semin Arthritis Rheum, 2019, 48(6): 1035-1040. DOI: 10.1016/j.semarthrit.2018.10.013 .
[19]
Merino-Vico A, Frazzei G, van Hamburg JP, et al. Targeting B cells and plasma cells in autoimmune diseases: from established treatments to novel therapeutic approaches[J]. Eur J Immunol, 2023, 53(1): e2149675. PMCID: PMC10099814. DOI: 10.1002/eji.202149675 .
[20]
Du W, Han M, Zhu X, et al. The multiple roles of B cells in the pathogenesis of Sjögren's syndrome[J]. Front Immunol, 2021, 12: 684999. PMCID: PMC8217880. DOI: 10.3389/fimmu.2021.684999 .
[21]
邓珊, 刘瑜, 邢一达, 等. 系统性红斑狼疮患者血清IgE水平及其与疾病活动性的关系[J]. 中华临床免疫和变态反应杂志, 2019, 13(1): 31-35. DOI: 10.3969 ∕j.issn.1673-8705.2019.01.006.
[22]
冯晓丽, 郭晓霞, 韩春滔. 血浆GAS5联合免疫学指标在系统性红斑狼疮患者诊断中的应用价值[J]. 临床研究, 2023, 31(12): 20-23. DOI: 10.12385/j.issn.2096-1278(2023)12-0020-04 .
[23]
贾亦斐, 俞霄凌, 胡纪. 血清炎性因子与系统性红斑狼疮疾病活动度、体液免疫的相关性及其诊断价值[J]. 广西医科大学学报, 2023, 40(9): 1522-1527. DOI: 10.16190/j.cnki.45-1211/r.2023.09.013 .
[24]
Liphaus BL, Silva SC, Palmeira P, et al. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement[J]. Front Immunol, 2024, 15: 1327255. PMCID: PMC10982494. DOI: 10.3389/fimmu.2024.1327255 .
[25]
Weitz IC, Liebman HA. Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP[J]. Br J Haematol, 2023, 203(1): 96-100. DOI: 10.1111/bjh.19070 .
[26]
Zhang Y, Liu F, Liang X, et al. Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients[J]. Clin Exp Med, 2023, 23(8): 4483-4491. DOI: 10.1007/s10238-023-01043-y .

Footnotes

所有作者均声明无利益冲突。

PDF(1097 KB)

Accesses

Citation

Detail

Sections
Recommended

/